申请人:Joseph Sajan
公开号:US20130190262A1
公开(公告)日:2013-07-25
The present invention provides an aminopyrazole compound, or a pharmaceutically acceptable salt thereof, that inhibits Chk1 and is useful in the treatment of cancer.
本发明提供了一种氨基吡唑化合物或其药学上可接受的盐,该化合物抑制Chk1并且在癌症治疗中有用。